Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer

Author:

Ueda Naoko12,Fujita Kohei1ORCID,Okuno Yoshiaki3,Nakatani Koichi1,Mio Tadashi1

Affiliation:

1. Division of Respiratory Medicine, Center for Respiratory Diseases; National Hospital Organization Kyoto Medical Center; Kyoto Japan

2. Department of Nephrology; National Hospital Organization Kyoto Medical Center; Kyoto Japan

3. Department of Haematology; National Hospital Organization Kyoto Medical Center; Kyoto Japan

Publisher

Wiley

Subject

General Medicine

Reference9 articles.

1. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008;Morton;Blood,2013

2. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features;Kantarjian;J Clin Oncol,1986

3. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes;Ratain;Ann Oncol,1992

4. Topoisomerase II inhibitor-related acute myeloid leukaemia;Pui;Br J Haematol,2000

5. Phase III trial of irinotecan plus Cisplatin versus etoposide plus cisplatin in chemotherapy-naive Korean patients with extensive-disease small cell lung cancer;Kim;Cancer Res Treat,2018

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Metachronous or Synchronous Presentation of Acute Myeloid Leukemia and Lung Cancer: A Single Center Experience;Akdeniz Medical Journal;2024-01-18

2. Expressions of TGF-β1 and VEGF in patients with acute myeloid leukemia and associations with prognosis;Revista Romana de Medicina de Laborator;2022-07-01

3. GOLD NANOPARTICLES AND CHEMOTHERAPEUTIC AGENTS;Annals of the Academy of Romanian Scientists Series on Physics and Chemistry;2020

4. Amrubicin/etoposide/topotecan;Reactions Weekly;2019-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3